Report Summary
Eternity Insights has published a new study on Global Low Molecular Weight Heparin Market focusing on key segments as by Type (Enoxaparin,Dalteparin,Tinzaparin,Fraxiparine), by Application (Treatment of Venous Thromboembolism,Complications of Pregnancy,Cardioversion of Atrial Fibrillation/Flutter,Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Low Molecular Weight Heparin Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Low Molecular Weight Heparin Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Low Molecular Weight Heparin Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Low Molecular Weight Heparin Market Segmentation:
Low Molecular Weight Heparin Market, By Type
- Enoxaparin
- Dalteparin
- Tinzaparin
- Fraxiparine
Low Molecular Weight Heparin Market, By Application
- Treatment of Venous Thromboembolism
- Complications of Pregnancy
- Cardioversion of Atrial Fibrillation/Flutter
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Low Molecular Weight Heparin market in terms of demand generation. The Low Molecular Weight Heparin market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Low Molecular Weight Heparin market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Low Molecular Weight Heparin Market Taxonomy:
To learn more about this report
Global Low Molecular Weight Heparin Market Competitive Landscape
The global Low Molecular Weight Heparin market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Aspen
- Sanofi-aventis
- Pfizer
- Opocrin
- CSBIO
- Dongying Tiandong Pharmaceutical
- Changzhou Qianhong Bio-pharma
- Techdow
- Yantai Dongcheng Pharmaceutical Group
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Enoxaparin,Dalteparin,Tinzaparin,Fraxiparine |
| By Application Outlook |
Treatment of Venous Thromboembolism,Complications of Pregnancy,Cardioversion of Atrial Fibrillation/Flutter,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Aspen,Sanofi-aventis,Pfizer,Opocrin,CSBIO,Dongying Tiandong Pharmaceutical,Changzhou Qianhong Bio-pharma,Techdow,Yantai Dongcheng Pharmaceutical Group |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Low Molecular Weight Heparin Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Low Molecular Weight Heparin Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Low Molecular Weight Heparin Industry Overview
2.1 Global Low Molecular Weight Heparin Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Low Molecular Weight Heparin Global Import Market Analysis
2.1.2 Low Molecular Weight Heparin Global Export Market Analysis
2.1.3 Low Molecular Weight Heparin Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Enoxaparin
2.2.2 Dalteparin
2.2.3 Tinzaparin
2.2.4 Fraxiparine
2.3.2 Complications of Pregnancy
2.3.3 Cardioversion of Atrial Fibrillation/Flutter
2.3.4 Others
2.4.2 Global Low Molecular Weight Heparin Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Low Molecular Weight Heparin Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Low Molecular Weight Heparin Manufacturer Market Share
2.4.5 Top 10 Low Molecular Weight Heparin Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Low Molecular Weight Heparin Market
2.4.7 Key Manufacturers Low Molecular Weight Heparin Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Low Molecular Weight Heparin Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Low Molecular Weight Heparin Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Low Molecular Weight Heparin Market Size Categorized by Regions
4.1 Global Low Molecular Weight Heparin Revenue, Sales and Market Share by Regions
4.1.1 Global Low Molecular Weight Heparin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Low Molecular Weight Heparin Revenue and Market Share by Regions (2015-2020)
4.2 Europe Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
4.3 APAC Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
4.4 North America Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
4.5 South America Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
5 Europe Low Molecular Weight Heparin Market Size Categorized by Countries
5.1 Europe Low Molecular Weight Heparin Sales, Revenue and Market Share by Countries
5.1.1 Europe Low Molecular Weight Heparin Sales by Countries (2015-2020)
5.1.2 Europe Low Molecular Weight Heparin Revenue by Countries (2015-2020)
5.1.3 Germany Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
5.1.4 UK Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
5.1.5 France Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
5.1.6 Russia Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
5.1.7 Italy Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
5.1.8 Spain Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
5.2 Europe Low Molecular Weight Heparin Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Low Molecular Weight Heparin Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
5.3.2 Europe Low Molecular Weight Heparin Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
6 Asia-Pacific Low Molecular Weight Heparin Market Size Categorized by Countries
6.1 Asia-Pacific Low Molecular Weight Heparin Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Low Molecular Weight Heparin Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Low Molecular Weight Heparin Revenue by Countries (2015-2020)
6.1.3 China Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
6.1.4 Japan Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
6.1.5 Korea Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
6.1.6 India Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
6.1.8 Australia Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Low Molecular Weight Heparin Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Low Molecular Weight Heparin Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Low Molecular Weight Heparin Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Low Molecular Weight Heparin Sales and Market Share by Application (2015-2020)
7 North America Low Molecular Weight Heparin Market Size Categorized by Countries
7.1 North America Low Molecular Weight Heparin Sales, Revenue and Market Share by Countries
7.1.1 North America Low Molecular Weight Heparin Sales by Countries (2015-2020)
7.1.2 North America Low Molecular Weight Heparin Revenue by Countries (2015-2020)
7.1.3 United States Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
7.1.4 Canada Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
7.1.5 Mexico Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
7.2 North America Low Molecular Weight Heparin Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Low Molecular Weight Heparin Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
7.3.2 North America Low Molecular Weight Heparin Revenue and Revenue Share by Type (2015-2020)
7.4 North America Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
8 South America Low Molecular Weight Heparin Market Size Categorized by Countries
8.1 South America Low Molecular Weight Heparin Sales, Revenue and Market Share by Countries
8.1.1 South America Low Molecular Weight Heparin Sales by Countries (2015-2020)
8.1.2 South America Low Molecular Weight Heparin Revenue by Countries (2015-2020)
8.1.3 Brazil Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
8.2 South America Low Molecular Weight Heparin Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Low Molecular Weight Heparin Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
8.3.2 South America Low Molecular Weight Heparin Revenue and Revenue Share by Type (2015-2020)
8.4 South America Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
9 Middle East and Africa Low Molecular Weight Heparin Market Size Categorized by Countries
9.1 Middle East and Africa Low Molecular Weight Heparin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Low Molecular Weight Heparin Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Low Molecular Weight Heparin Revenue by Countries (2015-2020)
9.1.3 GCC Countries Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
9.1.4 Turkey Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
9.1.5 Egypt Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
9.1.6 South Africa Low Molecular Weight Heparin Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Low Molecular Weight Heparin Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Low Molecular Weight Heparin Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Low Molecular Weight Heparin Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Application (2015-2020)
10 Global Low Molecular Weight Heparin Market Segment by Type
10.1 Global Low Molecular Weight Heparin Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Low Molecular Weight Heparin Sales and Market Share by Type (2015-2020)
10.1.2 Global Low Molecular Weight Heparin Revenue and Market Share by Type (2015-2020)
10.2 Enoxaparin Sales Growth Rate and Price
10.2.1 Global Enoxaparin Sales Growth Rate (2015-2020)
10.2.2 Global Enoxaparin Price (2015-2020)
10.3 Dalteparin Sales Growth Rate and Price
10.3.1 Global Dalteparin Sales Growth Rate (2015-2020)
10.3.2 Global Dalteparin Price (2015-2020)
10.4 Tinzaparin Sales Growth Rate and Price
10.4.1 Global Tinzaparin Sales Growth Rate (2015-2020)
10.4.2 Global Tinzaparin Price (2015-2020)
10.5 Fraxiparine Sales Growth Rate and Price
10.5.1 Global Fraxiparine Sales Growth Rate (2015-2020)
10.5.2 Global Fraxiparine Price (2015-2020)
11.1 Global Low Molecular Weight HeparinSales Market Share by Application (2015-2020)
11.2 Treatment of Venous Thromboembolism Sales Growth Rate (2015-2020)
11.3 Complications of Pregnancy Sales Growth Rate (2015-2020)
11.4 Cardioversion of Atrial Fibrillation/Flutter Sales Growth Rate (2015-2020)
11.5 Others Sales Growth Rate (2015-2020)
12.1 Global Low Molecular Weight Heparin Revenue, Sales and Growth Rate (2020-2027)
12.2 Low Molecular Weight Heparin Market Forecast by Regions (2020-2027)
12.2.1 Europe Low Molecular Weight Heparin Market Forecast (2020-2027)
12.2.2 APAC Low Molecular Weight Heparin Market Forecast (2020-2027)
12.2.3 North America Low Molecular Weight Heparin Market Forecast (2020-2027)
12.2.4 South America Low Molecular Weight Heparin Market Forecast (2020-2027)
12.2.5 Middle East & Africa Low Molecular Weight Heparin Market Forecast (2020-2027)
12.3 Low Molecular Weight Heparin Market Forecast by Type (2020-2027)
12.3.1 Global Low Molecular Weight Heparin Sales Forecast by Type (2020-2027)
12.3.2 Global Low Molecular Weight Heparin Market Share Forecast by Type (2020-2027)
12.4 Low Molecular Weight Heparin Market Forecast by Application (2020-2027)
12.4.1 Global Low Molecular Weight Heparin Sales Forecast by Application (2020-2027)
12.4.2 Global Low Molecular Weight Heparin Market Share Forecast by Application (2020-2027)
13 Analysis of Low Molecular Weight Heparin Industry Key Manufacturers
13.1 Aspen
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Aspen Low Molecular Weight Heparin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Aspen News
13.2 Sanofi-aventis
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Sanofi-aventis Low Molecular Weight Heparin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Sanofi-aventis News
13.3 Pfizer
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Pfizer Low Molecular Weight Heparin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Pfizer News
13.4 Opocrin
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Opocrin Low Molecular Weight Heparin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Opocrin News
13.5 CSBIO
13.5.1 Company Details
13.5.2 Product Information
13.5.3 CSBIO Low Molecular Weight Heparin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 CSBIO News
13.6 Dongying Tiandong Pharmaceutical
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Dongying Tiandong Pharmaceutical News
13.7 Changzhou Qianhong Bio-pharma
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Changzhou Qianhong Bio-pharma News
13.8 Techdow
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Techdow Low Molecular Weight Heparin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Techdow News
13.9 Yantai Dongcheng Pharmaceutical Group
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Yantai Dongcheng Pharmaceutical Group News
15 Appendix
